Macmillan invests in Neutrocheck sepsis at-home testing
Macmillan Cancer Support’s Innovation Impact Investment Portfolio has made its first investment – with £100,000 for 52 North Health’s Neutrocheck.
Digital Patient
Cera hits 10 million healthcare visits during Covid pandemic
Cera said early on it spotted the need to support certain cohorts in their own homes during the pandemic and scaled its operation through technology.
Digital Patient